Lung Cancer is a major health challenge being faced all across the globe. There have been many advances in the arena of early-stage lung cancer treatment but still many number of patients…
Category: Lung Cancer News
Study: Gamma Delta T Cells Could Target Small Cell Lung Cancer
Small cell lung cancer is the deadliest forms of lung cancer with less than 7% of patients surviving five years after lung cancer diagnosis. Immunotherapy has benefited many lung cancer patients but…
Study: Excess Abdominal Adiposity Linked With Increased Lung Cancer Risk
A new study has been published in the Journal of Thoracic Oncoplogy led by Joseph Barbi, PhD, and Sai Yendamuri, MD, MBA, FACS, of Roswell Park Comprehensive Cancer Center in Buffalo, New…
UCLA Study: Dietary Molecule Affects Lung Tumor Growth Differently by Sex
Lung cancer remains the leading cause behind cancer-related deaths worldwide. Researchers continue to search for new approaches to prevent or slow down this deadly disease. One such area is how metabolism influences…
Rare Genetic Mutation Raises Risk For Lung Cancer among Non-Smokers
Lung Cancer is the most common forms of cancers among both men and women in the United States and worldwide. American Cancer Society estimates that there will be around 229,410 new diagnoses…
Amgen-AstraZeneca Lung Cancer Drug Combo Shows Promising Results
Lung Cancer remains the leading cause of cancer-related deaths worldwide. A recent clinical trial has shown promising results in lung cancer patients. Amgen AMGN has announced positive results from a phase III…
Pancreatic Cancer Drug Show Promising Results in Lung Cancer
According to the American Cancer Society, the odds that a person will develop lung cancer is about 1 in 19. Also, more than ¾ of all lung cancers are non-small cell lung…
Withdrawal of Zepzelca in Second-Line Small Cell Lung Cancer
Jazz Pharmaceuticals plans for removal of lurbinectedin (Zepzelca) as second-line metastatic small cell lung cancer. The decision came after the confirmatory Phase 3 Lagoon trial failed on its primary endpoint of overall…